Cinuperone
Cinuperone is a multi-target competitive receptor ligand and σ receptor antagonist that acts on Dopamine D1, σ, Dopamine D1, and 5-HT2 receptors. Cinuperone shows significantly higher affinity for σ receptors than for Dopamine D1 receptors, and only exhibits moderate binding activity for dopamine D2 receptors. Cinuperone can be used in the research of central nervous system diseases.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 82117-51-9
- Formule: C23H24FN3O
- Masse moléculaire:377.46
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Voir tous les produits spécifiques à Isoform Sigma Receptor
MoreVoir tous les produits spécifiques à Isoform Dopamine Receptor
MoreVoir tous les produits spécifiques à Isoform 5-HT Receptor
More
Activité biologique
|
D2 Receptor 75 nM (IC50) |
D1 Receptor 6200 nM (IC50) |
5-HT2 Receptor 240 nM (IC50) |
Cinuperone potently inhibits [3H]-spiperone binding to dopamine2 receptors in rat striatal membranes with an IC50 of 76 nM[2].
Cinuperone weakly inhibits [3H]-SCH 23390 binding to dopamine1 receptors in rat striatal membranes with an IC50 of 6200 nM[2].
Cinuperone potently inhibits [3H]-haloperidol binding to σ receptors in rat cerebellar membranes with an IC50 of 54 nM[2].
Cinuperone moderately inhibits [3H]-ketanserin binding to 5-HT2 receptors in rat frontal cortex membranes with an IC50 of 240 nM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Cinuperone (10 μmol/kg; administered 30 minutes prior to apomorphine) antagonizes apomorphine-induced climbing in male albino mice with an ED50 of 10 μmol/kg[2].
Cinuperone (15 μmol/kg; administered 30 minutes prior to apomorphine) antagonizes apomorphine-induced yawning in male albino rats with an ED50 of 15 μmol/kg[2].
Cinuperone (0.97 μmol/kg; i.p.; administered 30 minutes prior to quipazine) antagonizes quipazine-induced head twitches in male albino rats with an ED50 of 0.97 μmol/kg[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 82117-51-9
-
Masse moléculaire 377.46
-
Formule C23H24FN3O
-
SMILES
O=C(C1=CC=C(F)C=C1)CCCN2CCN(C=3N=CC4=CC=CC=C4C3)CC2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Cinuperone Related Classifications
HY-W754019 Related Classifications
Powered by Bioz